60
Participants
Start Date
June 30, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
CRMD-001-Deferiprone
CRMD-001 represents unique formulations of Deferiprone. Subjects will be given one (900 mg) immediate release and two (900 mg) extended release tablets 1-3 hours prior to angiography and then every 12 hours for a total of 8 days
Placebo
3 placebo tablets will be given every 12 hours for a total of 8 days, beginning 1-3 hours prior to angiography
Ohio Health Research Institute, Columbus
St. Vincent Mercy Medical Center, Toledo
Cardiovascular Catheterization Labs at Fairfield, Fairfield
The Care Group, St. Vincent's Hospital, Indianapolis
Providence Hospital, Southfield
St. John Hospital and Medical Center, Detroit
Cardiac and Vascular Research Center of Northern Michigan, Petoskey
Oklahoma Cardiovascular Research Group, Oklahoma City
Lead Sponsor
CorMedix
INDUSTRY